×
Assembly Biosciences Price to Free Cash Flow Ratio 2010-2024 | ASMB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Assembly Biosciences price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
View More
Assembly Biosciences Price to Free Cash Flow Ratio 2010-2024 | ASMB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Assembly Biosciences price to free cash flow ratio from 2010 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19B
Dr Reddy's Laboratories (RDY)
$12B
BridgeBio Pharma (BBIO)
$4.3B
Bausch Health Cos (BHC)
$3B
Amphastar Pharmaceuticals (AMPH)
$2.1B
Supernus Pharmaceuticals (SUPN)
$2B
Taysha Gene Therapies (TSHA)
$434M
Personalis (PSNL)
$261M
Sol-Gel Technologies (SLGL)
$12M
Evoke Pharma (EVOK)
$7M
Teligent (TLGT)
$0M